Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products

Industrial Hemp Biotech Company Develops Everyday-Use Cannabigerol (CBG) Products

New York, New York, UNITED STATES


NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in global press after the Company revealed that it's actively developing a new retail market of everyday use products containing the "stem cell cannabinoid."

Photos accompanying this release are available at

http://www.globenewswire.com/newsroom/prs/?pkgid=32251

http://www.globenewswire.com/newsroom/prs/?pkgid=32253

http://www.globenewswire.com/newsroom/prs/?pkgid=32254

http://www.globenewswire.com/newsroom/prs/?pkgid=32255

After the announcement, the company was spotlighted in several major global publications, including:

Dental Tribune Online

Chemical & Engineering News

MJ Freeway

Pharmaceutical Commerce

Dental Products Report

The recent article by Dental Tribune Online quoted Dr. George E. Anastassov, MD, DDS, MBA and CEO of AXIM Biotech, stating, "It is known that certain cannabinoids act as effective bactericidal, anti-proliferative, and regenerating agents. For these reasons, AXIM has created a new category within the oral care consumer products market."

There are distinct differences between CBG and other cannabinoids - including widely recognized tetrahydrocannabinol or "THC." Industrial hemp is known to contain non-psychoactive cannabinoids and essential amino acids. According to Lekhram Changoer, Chief Technology Officer of AXIM Biotech, "CBG is the precursor of the other well-known cannabinoids. All-natural CBG provides benefits to oral health."

According to an article Cannabigerol (CBG): A Minor Cannabinoid With A Major Impact published by Medical Jane, "While most strains of cannabis are less than 10% CBG, industrial hemp strains test much higher. They have been tested as high as 94% CBG with as low as 0.001% THC."

Dr. Anastassov continues, "AXIM Biotech is providing health conscious and environmentally conscious consumers with all-natural alternatives. As an innovator within the global industrial hemp industry, the entire company is proud to enter the cosmetics and oral care markets with RENECANN™ and ORAXIMAX™ hemp CBG products. New everyday use products are estimated to be on store shelves this fall."

The following is a list of all-natural retail products containing hemp CBG coming from AXIM Biotech:

  • Toothpaste
  • Mouthwash
  • Dentifrice
  • Oral Gel (for minor cuts and sores)
  • Diaper Rash Cream
  • Moisturizers
  • Lotions
  • Lip Balm
  • Shampoo
  • Conditioner
  • Body Wash
  • Day Cream
  • Night Cream
  • Eye Cream

AXIM Biotech products are tested and free of heavy metals, pesticides, fungi or bacteria.

AXIM Biotech has been featured by media outlets including: FOX Business, CRAINS New York, MainStreet.com, MJ Freeway, Chemical & Engineering News, Dental Tribune, Pharmaceutical Commerce, Dental Products Report and MJI News. For more information, visit AXIM Biotech's website.

To arrange for media interviews, contact Andrew Hard, Public Relations Spokesperson, at Andrew.Hard@CMWmedia.com or call 858-380-5478.

About AXIM:

AXIM Biotechnologies, Inc. (OTC:AXIM) is an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products where we prioritize the well-being of our customers while embracing a solid fiscal strategy. For more information, visit the Company website at www.AXIMBiotech.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Axim Biotechnologies, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

AXIM Biotechnologies does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell, and distribute hemp-based products.

The photos are also available at Newscom, www.newscom.com, and via AP PhotoExpress.



        
Cannabigerol (CBG) Oral Care Products ORAXIMAX (TM) RENECANN (TM) RENECANN (TM) Day & Night Cream

Contact Data